NANOCOCHLEATE: A NOVEL APPROACH FOR DELIVERY OF BIOLOGICAL MOLECULES
AbstractNanocochleate is a novel lipid-based drug delivery system in which the liposomal vesicles are converted into nanocochleate by the addition of Calcium divalent cation. This technology involves encochleation of the drug for overcoming problems such as poor solubility, poor permeability, and poor oral bioavailability. This novel lipid-based formulation approach is applicable for the category of drugs like BCS class III drugs, BCS class IV drugs. Applications of this technology can also be extended to macromolecules as well as small molecule drugs that are lipophilic with poor oral bioavailability. It is appropriate for oral as well as systemic administration of biologically active molecules, including drugs, genes, proteins, peptides, and vaccine antigens. This article covers multiple aspects of Nanocochleate drug delivery system, such as its definition, composition, method of preparation, and mechanism of permeation. The article also elaborates on various advantages, disadvantages, and applications of Nanocochleate drug delivery system. The article highlights the potential of this novel system for oral as well as systemic delivery of chemical and biological drug products.
Article Information
6
3581-3592
745
1045
English
IJPSR
V. Yadav, B. Parab and S. Shidhaye *
Department of Pharmaceutics, Vivekanand Education Society’s College of Pharmacy, Mumbai, Maharashtra, India.
s.shidhaye@ves.ac.in
26 April 2020
24 May 2021
10 June 2021
10.13040/IJPSR.0975-8232.12(7).3581-92
01 July 2021
Download